Cargando…

The role of (18)F-FDG PET CT in common gynaecological malignancies

[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography ((18)F-FDG PET CT) has increasing clinical applications supplementing conventional TVUS, CT and MRI imaging in assessing ovarian, cervical and endometrial cancer. The published literature on the applications of (18)F-FDG PET CT show...

Descripción completa

Detalles Bibliográficos
Autores principales:	Narayanan, Priya, Sahdev, Anju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Institute of Radiology. 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963379/ https://www.ncbi.nlm.nih.gov/pubmed/28830238 http://dx.doi.org/10.1259/bjr.20170283

Ejemplares similares

The role of FDG-PET/CT in gynaecological cancers
por: Rockall, Andrea G, et al.
Publicado: (2012)

18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature
por: Allahqoli, Leila, et al.
Publicado: (2023)

CT, MRI and PET imaging in peritoneal malignancy
por: Patel, Chirag M., et al.
Publicado: (2011)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

The Role of [(18)F]FDG-PET/CT in Predicting Malignant Transformation of Plexiform Neurofibromas in Neurofibromatosis-1
por: Tovmassian, David, et al.
Publicado: (2016)

Colonic Malignant Melanoma: (18)F-FDG PET/CT Findings
por: Kaya, Eser, et al.
Publicado: (2018)

Impact of (18)F-FDG PET/CT on target volume delineation in recurrent or residual gynaecologic carcinoma
por: Vees, Hansjörg, et al.
Publicado: (2012)

Evaluation of Malignancy Risk in 18F-FDG PET/CT Thyroid Incidentalomas
por: Larg, Maria-Iulia, et al.
Publicado: (2019)

Contribution of (18)F-FDG PET/CT to Staging of Head and Neck Malignancies
por: Ceylan, Yeşim, et al.
Publicado: (2018)

(18)F FDG-PET/CT of malignant thymoma with pleural and diaphragmatic metastases
por: Gajendra, Smeeta, et al.
Publicado: (2016)

Cardiac Metastasis of Malignant Melanoma Detected by (18)F-FDG PET/CT
por: Zhang, Hongzhe, et al.
Publicado: (2023)

Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies
por: Hameeduddin, Ayshea, et al.
Publicado: (2015)

Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast (18)F-FDG PET/MRI compared to (18)F-FDG PET/CT and CT
por: Kirchner, Julian, et al.
Publicado: (2017)

F-18-FDG PET/CT findings of paraneoplastic dermatoses
por: Suga, Kazuyoshi
Publicado: (2022)

The Role and Potential of (18)F-FDG PET/CT in Malignant Melanoma: Prognostication, Monitoring Response to Targeted and Immunotherapy, and Radiomics
por: Filippi, Luca, et al.
Publicado: (2022)

Value of (18)F-FDG PET/CT in the detection of occult malignancy in patients with dermatomyositis
por: Li, Xiuming, et al.
Publicado: (2020)

Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma
por: CASTALDI, P., et al.
Publicado: (2013)

Role of 18F-FDG PET/CT in the Carcinoma of the Uterus: A Review of Literature
por: Musto, Alessandra, et al.
Publicado: (2014)

The role of (18)F-FDG PET/CT in primary cutaneous lymphoma: an educational review
por: McDonald, Elysia O., et al.
Publicado: (2023)

Comparison of (18)F-FDG PET/CT and ultrasound in staging of patients with malignant melanoma
por: Weber, Philipp, et al.
Publicado: (2022)

Common hepatic artery aneurysm detected by 18F-FDG PET/CT Imaging
por: F, Janata, et al.
Publicado: (2021)

Scar Sarcoidosis on (18)F-FDG PET/CT
por: Arora, Saurabh, et al.
Publicado: (2019)

18F-FDG PET/CT and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

Emerging role of 18F-FDG PET/CT in Castleman disease: a review
por: Koa, Benjamin, et al.
Publicado: (2021)

Primary Benign Intraosseous Meningioma on (18)F-FDG PET/CT Mimicking Malignancy
por: Kim, Ho Seong, et al.
Publicado: (2014)

Added value of regional (18)F-FDG PET/MRI-assisted whole-body (18)F-FDG PET/CT in malignant ascites with unknown primary origin
por: Fu, Yiru, et al.
Publicado: (2023)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

Is There a Role for [(18)F]FDG PET-CT in Staging MALT Lymphoma?
por: Cohen, Dan, et al.
Publicado: (2022)

The Role of 18F-FDG PET/CT in the Evaluation of Gastric Cancer Recurrence
por: Cayvarlı, Hakan, et al.
Publicado: (2014)

The Role of 18F-FDG PET/CT in the Primary Staging of Gastric Cancer
por: Filik, Mustafa, et al.
Publicado: (2015)

The Role of (18)F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion
por: Sun, Yajuan, et al.
Publicado: (2016)

[(18)F]FDG-PET/CT in Hodgkin Lymphoma: Current Usefulness and Perspectives
por: Kanoun, Salim, et al.
Publicado: (2018)

[(18)F]FDG PET/CT in the Evaluation of Melanoma Patients Treated with Immunotherapy
por: Mangas Losada, María, et al.
Publicado: (2023)

The sensitivity and specificity of (18)F-FDG PET/CT in spinal leptomeningeal metastases: the synergistic effect of the (18)F-FDG PET-CT to gadolinium-enhanced MRI
por: Luo, Zhe-Huang, et al.
Publicado: (2023)

The Role of (18)F-FDG PET/CT in the Management of the Autoimmune Thyroid Diseases
por: Małkowski, Bogdan, et al.
Publicado: (2019)

Role of 18F-FDG PET/CT in the Follow-up of Colorectal Cancer
por: Milardovic, Renata, et al.
Publicado: (2020)

Prevalence and malignancy risk of focal colorectal incidental uptake detected by (18)F-FDG-PET or PET/CT: a meta-analysis
por: Treglia, Giorgio, et al.
Publicado: (2014)

Imaging of Gastric Cancer Metabolism Using 18 F-FDG PET/CT
por: Yun, Mijin
Publicado: (2014)

The role of (18)F-FDG PET/CT imaging in patient with malignant PEComa treated with mTOR inhibitor
por: Sun, Lu, et al.
Publicado: (2015)

(18)F-FDG PET/CT in Pleural Epithelioid Hemangioendothelioma
por: Albano, Domenico, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o3pcul2uv75r4n5hbg61h8d82f